AI for accelerated antibody discovery Traditionally, mAbs are initially discovered (hit identification, or HI) through experimental techniques, like hybridoma screening or high throughput ...

We have capabilities that equip us with the toolkit needed throughout the whole antibody development process, from hit identification to mid-scale production,” said Yamashita. “Our aim is to ...

the first DTI approved for HIT, is a bivalent thrombin inhibitor that is cleared by the kidneys. Neither argatroban nor lepirudin demonstrates cross-reactivity with heparin-induced antibodies, and ...

NASHVILLE, Tenn. (WSMV) - Vanderbilt University Medical Center will lead a massive project aimed at discovering therapeutic antibodies through the use of Artificial Intelligence. Therapeutic ...

With Libera Bio’s technology enabling the intracellular delivery of monoclonal antibodies, small molecules and more, drug developers can hit formerly inaccessible high-value targets and create ...